MOISSAK Trademark

Trademark Overview

On Wednesday, December 21, 2011, a trademark application was filed for MOISSAK with the United States Patent and Trademark Office. The USPTO has given the MOISSAK trademark a serial number of 85501212. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 3, 2014. This trademark is owned by AstraZeneca AB. The MOISSAK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, inflammation, infections, gastrointestinal diseases and disorders, and nervous system diseases and disorders
moissak

General Information

Serial Number85501212
Word MarkMOISSAK
Filing DateWednesday, December 21, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 3, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, inflammation, infections, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-151 85
SE

Trademark Events

Event DateEvent Description
Monday, February 3, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 3, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, March 31, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 29, 2013EXAMINER'S AMENDMENT ENTERED
Friday, March 29, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2013EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, October 15, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, October 15, 2012FINAL REFUSAL E-MAILED
Monday, October 15, 2012FINAL REFUSAL WRITTEN
Monday, October 15, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2012ASSIGNED TO LIE
Tuesday, October 2, 2012ASSIGNED TO LIE
Monday, September 24, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 9, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 9, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 28, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 27, 2012ASSIGNED TO EXAMINER
Tuesday, January 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

moissak disorders diseases substances pharmaceutical preparations treatment gastrointestinal nervous infections system